Guadalupe Sabio

Guadalupe Sabio Buzo (born 4 June 1977) is a Spanish scientist and Professor at the Spanish National Cardiovascular Research Centre, which is part of the Carlos III Health Institute. Her research considers stress-activated kinases and the development of diseases associated with obesity. She was awarded the Princess of Girona Foundation Scientist Prize in 2012 and selected as one of the Top 100 Women Leaders in Spain in 2017.

Guadalupe Sabio
Born4 June 1977
Badajoz
NationalitySpanish
Alma materUniversity of Extremadura
University of Dundee
Scientific career
InstitutionsSpanish National Cardiovascular Research Centre
Howard Hughes Medical Institute
WebsiteSabio Lab

Early life and education

Sabio was born in Badajoz in 1977. She attended the Colegio del Santo Ángel and the Institute of San Fernando.[1] She studied veterinary sciences at the University of Extremadura, and graduated in 2000 with an extraordinary award.[2] She has said that she chose to study veterinary science as she liked animals very much, and that this could help her understand the origins of diseases.[1] She moved to the United Kingdom for her doctoral studies, where she joined the University of Dundee as a Medical Research Council European graduate student. She completed her doctorate on p38 delta kinases in 2005.[3] Whilst her PhD had taught her how to research in vitro, Sabio was keen to translate her research into mouse models.[3] She joined the research group of Roger Davis at the Howard Hughes Medical Institute where she studied the impact of stress on kinases proteins. In 2009 she was awarded Santiago Ramón y Cajal funding to join a biotechnology laboratory in Spain.[3]

Research and career

Sabio joined the Spanish National Cardiovascular Research Centre in 2011.[4] Sabio is investigating the molecular mechanisms that are associated with obesity, and how they can predispose patients to other conditions such as hepatocellular carcinoma.[5][6] Hepatocellular carcinoma is a type of liver carcinoma, and the second most common cause of cancer-related deaths. Whilst there is chemotherapy available, it can only increase a patient's life by three months. Sabio researches p38gamma, a kinase protein that is expressed excessively in patients with hepatocellular carcinoma, and whether inhibition of this protein could reduce the cancer. She is developing drugs that inhibit p38gamma for the treatment of liver cancer.[7] She has also investigated the C-Jun N-terminal kinases (JNK) protein, which is known to control obesity.[1]

She believes that obesity will be a major challenge for future generations, and it should be taken as seriously as smoking.[8][9] By considering fat, adipose tissue, as an endocrine organ she believes people will think more carefully about how to care for it.[10] She believes that the best antidotes to obesity are exercise and diet.[4][11] In 2017 Sabio was inducted into the European Molecular Biology Organization.[12]

Sabio has been involved in several initiatives to promote women in science.[13] She has called for more research into the symptoms of disease experienced by women.[5]

Selected publications

Awards and honours
Guadalupe Sabio winning three Star of Madrid award

References
  1. "Vencer la obesidad puede ser más difícil que vencer el cáncer". Hoy (in European Spanish). 2016-12-18. Retrieved 2019-11-03.
  2. "Jurado-Dra. Guadalupe Sabio Buzo". Premios a la investigación FJS (in European Spanish). Retrieved 2019-11-04.
  3. "Alumni Interview | Guadalupe Sabio". MRC. Retrieved 2019-11-04.
  4. EFE. "La científica Guadalupe Sabio: Estar obeso es jugar a la ruleta rusa". eldiario.es (in Spanish). Retrieved 2019-11-04.
  5. "Investigar con perspectiva de género es básico para salvar la vida de las mujeres y prevenir enfermedades". www.publico.es. Retrieved 2019-11-03.
  6. ELDIAdigital, eldiadigital es. "Guadalupe Sabio defiende el papel de la grasa como órgano endocrino". eldiadigital.es Periódico de Castilla-La Mancha (in Spanish). Retrieved 2019-11-03.
  7. "Descubren una nueva diana terapéutica para tratar el cáncer de hígado". Red Leonardo (in Spanish). 2019-04-10. Retrieved 2019-11-03.
  8. "Guadalupe Sabio: "Hacen falta medidas más drásticas contra la obesidad"". ELMUNDO (in Spanish). 2019-10-27. Retrieved 2019-11-03.
  9. "Peligros sobre la obesidad". La Vanguardia. 2019-03-17. Retrieved 2019-11-04.
  10. Mancha, Universidad de Castilla-La. "La investigadora del CNIC Guadalupe Sabio defiende en la UCLM el papel de la grasa como órgano endocrino". Universidad de Castilla - La Mancha. Retrieved 2019-11-04.
  11. Moreno, Ana García (2019-08-06). "Hay muchas farmacéuticas en busca de la pastilla contra la obesidad. Pero aún no existe nada efectivo". El País (in Spanish). ISSN 1134-6582. Retrieved 2019-11-04.
  12. "Guadalupe Sabio entra a formar parte de los jóvenes más brillantes de la EMBO". Red Leonardo (in Spanish). 2017-11-03. Retrieved 2019-11-03.
  13. López, Pepa (2019-07-19). "Guadalupe Sabio: "la presencia minoritaria de mujeres en la ciencia es algo que se está empezando a corregir ahora"". Trendencias (in Spanish). Retrieved 2019-11-03.
  14. "Las científicas españolas incrementan su presencia en Wikipedia - Grupo L'Oréal". www.loreal.es (in European Spanish). Retrieved 2019-11-03.
  15. "Guadalupe Sabio, 2012 FPdGi Scientific Research Award". en.fpdgi.org. Retrieved 2019-11-03.
  16. "Guadalupe Sabio: 'La base del éxito es saber fracasar'". ELMUNDO (in Spanish). 2014-03-27. Retrieved 2019-11-03.
  17. "La pacense Guadalupe Sabio, premiada por una investigación sobre la obesidad". Hoy (in Spanish). 2018-09-13. Retrieved 2019-11-03.
  18. "Nueve mujeres sobresalientes y una recién nacida, ganadoras de los Premios MAS". MAS: Mujeres a seguir. 2019-10-22. Retrieved 2019-11-03.
  19. "Guadalupe Sabio, Ana Pastor, Olga Felip, Joana Pastrana, Sonia Díez y Mar González, galardonadas en la VI Premios MAS". La Vanguardia. 2019-10-23. Retrieved 2019-11-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.